These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2712541)

  • 1. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
    Kenny GE; Hooton TM; Roberts MC; Cartwright FD; Hoyt J
    Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB; Cassell GH; Canupp KC; Fernandes PB
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
    Waites KB; Duffy LB; Schmid T; Crabb D; Pate MS; Cassell GH
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Duffy LB
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
    Kenny GE; Cartwright FD
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A twelve-year retrospective analysis of prevalence and antimicrobial susceptibility patterns of Ureaplasma spp. and Mycoplasma hominis in the province of Lower Silesia in Poland.
    Kasprzykowska U; Sobieszczańska B; Duda-Madej A; Secewicz A; Nowicka J; Gościniak G
    Eur J Obstet Gynecol Reprod Biol; 2018 Jan; 220():44-49. PubMed ID: 29154180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
    Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
    Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
    Furneri PM; Bisignano G; Cerniglia G; Nicoletti G; Cesana M; Tempera G
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
    Krausse R; Schubert S
    Clin Microbiol Infect; 2010 Nov; 16(11):1649-55. PubMed ID: 20047607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
    Hoban D; DeGagne P; Witwicki E
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB; Crabb DM; Bing X; Duffy LB
    Antimicrob Agents Chemother; 2003 Jan; 47(1):161-5. PubMed ID: 12499185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.
    Knapp JS; Hale JA; Neal SW; Wintersheid K; Rice RJ; Whittington WL
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2442-5. PubMed ID: 8585723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.